Indicators of loco-regional recurrence in breast cancer

European Journal of Surgical Oncology

Volumn 26, Issue 4, 2000, Pages 357-362

  Sundquist, M ^a   Thorstenson, S ^a   Klintenberg, C ^b   Brudin, L ^a   Nordenskjold B ^b  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Lymphovascular invasion; Nottingham histological grade; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033941367     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0898     Document Type: Article

References (36)

1. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 320:1989;822-828.
2. Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst. 86:1994;717-722.
3. Recht A, Silen W, Schnitt SJ, Connolly JL, Gelman RS, Rose MA, Silver B, Harris JR. Time course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys. 15:1988;255-261.
4. Tennvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol. 32:1993;641-646.
5. Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists" Collaborative Group. N Engl J Med. 333:1995;1444-1455.
6. Arriagada R, Rutqvist LE, Mattsson A, Kramer A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 13:1995;2869-2878.
7. Overgaard M, Hansen PS, Overgaard J. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 337:1997;949-955.
8. Ragaz J, Jackson SM, Le N. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
9. Gyenes G, Fornander T, Carlens P, Rutqvist LE. Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 28:1994;1235-1241.
10. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys. 36:1996;899-905.
11. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 22:1992;887-896.
12. Haybittle JL, Brinkley D, Houghton J, A'Hern RP, Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. Br Med J. 298:1989;1611-1614.
13. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 12:1994;447-453.
14. Jones JM, Ribeiro GG. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 40:1989;204-208.
15. Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol. 15:1997;1348-1353.
16. Liljegren G, Lindgren A, Bergh J, Nordgren H, Tabar L, Holmberg L. Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol. 8:1997;235-241.
17. MacMillan RD, Purushotham AD, Cordiner C, Dobson H, Mallon E, George WD. Predicting local recurrence by correlating pre-operative mammographic findings with pathological risk factors in patients with breast cancer. Br J Radiol. 68:1995;445-449.
18. McCready DR, Hanna W, Kahn H, Chapman JA, Wall J, Fish EB, Lickley HL. Factors associated with local breast cancer recurrence after lumpectomy alone. Ann Surg Oncol. 3:1996;358-366.
19. Dalberg K, Mattsson A, Rutqvist LE, Johansson U, Riddez L, Sandelin K. Breast conserving surgery for invasive breast cancer: risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat. 43:1997;73-86.
20. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;15-18.
21. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 87:1995;19-27.
22. Pinder SE, Ellis IO, Galea M, O'Rouke S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 24:1994;41-47.
23. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H. Risk factors in breast-conservation therapy - see comments. J Clin Oncol. 12:1994;653-660.
24. Neff PT, Bear HD, Pierce CV, Grimes MM, Fleming MD, Neifeld JP, Arthur D, Horsley JS, Lawrence W, Kornstein MJ. Long-term results of breast conservation therapy for breast cancer. Ann Surg. 223:1996;709-716.
25. Locker AP, Ellis IO, Morgan DA, Elston CW, Mitchell A, Blamey RW. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg. 76:1989;890-894.
26. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 22:1996;17-22.
27. O'Rourke S, Galea MH, Morgan D, Euhus D, Pinder S, Ellis IO, Elston CW, Blamey RW. Local recurrence after simple mastectomy. Br J Surg. 81:1994;386-389.
28. Swedish Breast Cancer Co-operative Group. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group. J Natl Cancer Inst. 88:1996;1543-1549.
29. Elston CW. Grading of invasive carcinoma of the breast. In Page DL, Anderson TJ (eds) Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone. 1987;300-311.
30. Orbo A, Stalsberg H, Kunde D. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics. Cancer. 66:1990;972-977.
31. Staal O, Carstensen J, Hatschek T, Nordenskjöld B. Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. Br J Cancer. 66:1992;706-711.
32. Stat Soft I. Computer program manual. Tulsa, OK: Stat Soft, inc. 1995.
33. Kollias J, Elston CW, Ellis IO, Robertson JF, Blamey RW. Early-onset breast cancer - histopathological and prognostic considerations. Br J Cancer. 75:1997;1318-1323.
34. Sundquist M, Thorstenson S, Brudin L, Nordenskjöld B. Applying the Nottingham Prognostic Index to a Swedish breast cancer population. Breast Cancer Res Treat. 53:1999;1-8.
35. Stål O, Klintenberg C, Sullivan S. Overexpression of c-erbB-2 protein and locoregional recurrence in node positive breast cancer. Breast. 6:1997;354-360.
36. Jansson T, Inganäs M, Sjögren S, Norberg T, Lindgren A, Holmberg L, Bergh J. p-53 status predicts survival in breast cancer patients treated with or without postoperative radiotherapy. J Clin Oncol. 13:1995;2745-2751.